Multilaboratory approach to preclinical evaluation of vaccine immunogens for placental malaria

Infection and Immunity

Volumn 81, Issue 2, 2013, Pages 487-495

  Fried, Michal ^a,b   Avril, Marion ^a   Chaturvedi, Richa ^a   Fernandez, Pablo ^c,d   Lograsso, Joseph ^a   Narum, David ^b   Nielsen, Morten A ^e   Oleinikov, Andrew V ^a   Resende, Mafalda ^e   Salanti, Ali ^e   Saveria, Tracy ^a   Williamson, Kathryn ^a   Dicko, Alassane ^f   Scherf, Artur ^c,d   Smith, Joseph D ^a   Theander, Thor G ^e   Duffy, Patrick E ^a,b  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c INSTITUT PASTEUR   (France)

^d CNRS   (France)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f UNIVERSITY OF BAMAKO   (Mali)

Author keywords

[No Author keywords available]

Indexed keywords

DUFFY BINDING PROTEIN; ERYTHROCYTE MEMBRANE PROTEIN 1; MEMBRANE ANTIGEN; REAGENT; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VAR2CSA SURFACE ANTIGEN;

ALLELE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; EUKARYOTE; FLOW CYTOMETRY; IMMUNIZATION; IN VITRO STUDY; LABORATORY; MOLECULAR RECOGNITION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLACENTA MALARIA; PRIORITY JOURNAL; PROKARYOTE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHONDROITIN SULFATES; COHORT STUDIES; FEMALE; HUMANS; IMMUNE SERA; IMMUNOGLOBULIN G; LONGITUDINAL STUDIES; MALARIA VACCINES; MALARIA, FALCIPARUM; PLACENTA; PLASMODIUM FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; RATS; RECOMBINANT PROTEINS;

EID: 84873032906     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01106-12     Document Type: Article

References (39)

1. Granja AC, Machungo F, Gomes A, Bergstrom S, Brabin B. 1998. Malaria-related maternal mortality in urban Mozambique. Ann. Trop. Med. Parasitol. 92:257-263.
2. Steketee RW, Nahlen BL, Parise ME, Menendez C. 2001. The burden of malaria in pregnancy in malaria-endemic areas. Am. J. Trop. Med. Hyg. 64:28-35.
3. Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B, Newman RD. 2007. Epidemiology and burden of malaria in pregnancy. Lancet Infect. Dis. 7:93-104.
4. Fried M, Duffy PE. 1996. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 272:1502-1504.
5. Fried M, Duffy PE. 1998. Maternal malaria and parasite adhesion. J. Mol. Med. (Berl.) 76:162-171.
6. Ricke CH, Staalsoe T, Koram K, Akanmori BD, Riley EM, Theander TG, Hviid L. 2000. Plasma antibodies from malaria-exposed pregnant women recognize variant surface antigens on Plasmodium falciparuminfected erythrocytes in a parity-dependent manner and block parasite adhesion to chondroitin sulfate A. J. Immunol. 165:3309-3316.
7. Staalsoe T, Shulman CE, Bulmer JN, Kawuondo K, Marsh K, Hviid L. 2004. Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria. Lancet 363:283-289.
8. Duffy PE. 2003. Maternal immunization and malaria in pregnancy. Vaccine 21:3358-3361.
9. Salanti A, Staalsoe T, Lavstsen T, Jensen AT, Sowa MP, Arnot DE, Hviid L, Theander TG. 2003. Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Mol. Microbiol. 49: 179-191.
10. Tuikue Ndam NG, Salanti A, Bertin G, Dahlback M, Fievet N, Turner L, Gaye A, Theander T, Deloron P. 2005. High level of var2csa transcription by Plasmodium falciparum isolated from the placenta. J. Infect. Dis. 192:331-335.
11. Gamain B, Trimnell AR, Scheidig C, Scherf A, Miller LH, Smith JD. 2005. Identification of multiple chondroitin sulfate A (CSA)-binding domains in the var2CSA gene transcribed in CSA-binding parasites. J. Infect. Dis. 191:1010-1013.
12. Dahlback M, Rask TS, Andersen PH, Nielsen MA, Ndam NT, Resende M, Turner L, Deloron P, Hviid L, Lund O, Pedersen AG, Theander TG, Salanti A. 2006. Epitope mapping and topographic analysis of VAR2CSA DBL3X involved in P. falciparum placental sequestration. PLoS Pathog. 2:e124. doi:10.1371/journal.ppat.0020124.
13. Resende M, Nielsen MA, Dahlback M, Ditlev SB, Andersen P, Sander AF, Ndam NT, Theander TG, Salanti A. 2008. Identification of glycosaminoglycan binding regions in the Plasmodium falciparum encoded placental sequestration ligand, VAR2CSA. Malar. J. 7:104. doi:10.1186/1475-2875-7-104.
14. Khunrae P, Philip JM, Bull DR, Higgins MK. 2009. Structural comparison of two CSPG-binding DBL domains from the VAR2CSA protein important in malaria during pregnancy. J. Mol. Biol. 393:202-213.
15. Dahlback M, Nielsen MA, Salanti A. 2010. Can any lessons be learned from the ambiguous glycan binding of PfEMP1 domains? Trends Parasitol. 26:230-235.
16. Salanti A, Dahlback M, Turner L, Nielsen MA, Barfod L, Magistrado P, Jensen AT, Lavstsen T, Ofori MF, Marsh K, Hviid L, Theander TG. 2004. Evidence for the involvement of VAR2CSA in pregnancy-associated malaria. J. Exp. Med. 200:1197-1203.
17. Khunrae P, Dahlback M, Nielsen MA, Andersen G, Ditlev SB, Resende M, Pinto VV, Theander TG, Higgins MK, Salanti A. 2010. Full-length recombinant Plasmodium falciparum VAR2CSA binds specifically to CSPG and induces potent parasite adhesion-blocking antibodies. J. Mol. Biol. 397:826-834.
18. Avril M, Hathaway MJ, Srivastava A, Dechavanne S, Hommel M, Beeson JG, Smith JD, Gamain B. 2011. Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not crossinhibit different placental-type parasite isolates. PLoS One 6:e16622. doi: 10.1371/journal.pone.0016622.
19. Barfod L, Nielsen MA, Turner L, Dahlback M, Jensen AT, Hviid L, Theander TG, Salanti A. 2006. Baculovirus-expressed constructs induce immunoglobulin G that recognizes VAR2CSA on Plasmodium falciparum- infected erythrocytes. Infect. Immun. 74:4357-4360.
20. Magistrado P, Salanti A, Tuikue Ndam NG, Mwakalinga SB, Resende M, Dahlback M, Hviid L, Lusingu J, Theander TG, Nielsen MA. 2008. VAR2CSA expression on the surface of placenta-derived Plasmodium falciparum-infected erythrocytes. J. Infect. Dis. 198:1071-1074.
21. Tuikue Ndam NG, Salanti A, Le-Hesran JY, Cottrell G, Fievet N, Turner L, Sow S, Dangou JM, Theander T, Deloron P. 2006. Dynamics of anti-VAR2CSA immunoglobulin G response in a cohort of Senegalese pregnant women. J. Infect. Dis. 193:713-720.
22. Gangnard S, Tuikue Ndam NG, Gnidehou S, Quiviger M, Juillerat A, Faure G, Baron B, Viwami F, Deloron P, Bentley GA. 2010. Functional and immunological characterization of the var2CSA-DBL5epsilon domain of a placental Plasmodium falciparum isolate. Mol. Biochem. Parasitol. 173:115-122.
23. Tutterrow YL, Avril M, Singh K, Long CA, Leke RJ, Sama G, Salanti A, Smith JD, Leke RG, Taylor DW. 2012. High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission. Infect. Immun. 80:1479-1490.
24. Oleinikov AV, Rossnagle E, Francis S, Mutabingwa TK, Fried M, Duffy PE. 2007. Effects of sex, parity, and sequence variation on seroreactivity to candidate pregnancy malaria vaccine antigens. J. Infect. Dis. 196:155-164.
25. Avril M, Hathaway MJ, Cartwright MM, Gose SO, Narum DL, Smith JD. 2009. Optimizing expression of the pregnancy malaria vaccine candidate, VAR2CSA in Pichia pastoris. Malar. J. 8:143. doi:10.1186 /1475-2875-8-143.
26. Fernandez P, Petres S, Mecheri S, Gysin J, Scherf A. 2010. Straintranscendent immune response to recombinant Var2CSA DBL5-epsilon domain block P. falciparum adhesion to placenta-derived BeWo cells under flow conditions. PLoS One 5:e12558. doi:10.1371/journal.pone. 0012558.
27. Salanti A, Resende M, Ditlev SB, Pinto VV, Dahlback M, Andersen G, Manczak T, Theander TG, Nielsen MA. 2010. Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies. Malar. J. 9:11. doi:10.1186/1475-2875-9-11.
28. Oleinikov AV, Francis SE, Dorfman JR, Rossnagle E, Balcaitis S, Getz T, Avril M, Gose S, Smith JD, Fried M, Duffy PE. 2008. VAR2CSA domains expressed in Escherichia coli induce cross-reactive antibodies to native protein. J. Infect. Dis. 197:1119-1123.
29. Fried M, Nosten F, Brockman A, Brabin BJ, Duffy PE. 1998. Maternal antibodies block malaria. Nature 395:851-852.
30. Duffy PE, Fried M. 2011. Pregnancy malaria: cryptic disease, apparent solution. Mem. Inst. Oswaldo Cruz 106(Suppl 1):64-69.
31. Snounou G, Zhu X, Siripoon N, Jarra W, Thaithong S, Brown KN, Viriyakosol S. 1999. Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Trans. R. Soc. Trop. Med. Hyg. 93:369-374.
32. Avril M, Kulasekara BR, Gose SO, Rowe C, Dahlback M, Duffy PE, Fried M, Salanti A, Misher L, Narum DL, Smith JD. 2008. Evidence for globally shared, cross-reacting polymorphic epitopes in the pregnancyassociated malaria vaccine candidate VAR2CSA. Infect. Immun. 76:1791-1800.
33. Fernandez P, Viebig NK, Dechavanne S, Lepolard C, Gysin J, Scherf A, Gamain B. 2008. Var2CSA DBL6-epsilon domain expressed in HEK293 induces limited cross-reactive and blocking antibodies to CSA binding parasites. Malar. J. 7:170. doi:10.1186/1475-2875-7-170.
34. Nielsen MA, Pinto VV, Resende M, Dahlback M, Ditlev SB, Theander TG, Salanti A. 2009. Induction of adhesion-inhibitory antibodies against placental Plasmodium falciparum parasites by using single domains of VAR2CSA. Infect. Immun. 77:2482-2487.
35. Pinto VV, Ditlev SB, Jensen KE, Resende M, Dahlback M, Andersen G, Andersen P, Theander TG, Salanti A, Nielsen MA. 2011. Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA. PLoS One 6:e17942. doi:10.1371/ journal.pone.0017942.
36. Avril M, Cartwright MM, Hathaway MJ, Hommel M, Elliott SR, Williamson K, Narum DL, Duffy PE, Fried M, Beeson JG, Smith JD. 2010. Immunization with VAR2CSA-DBL5 recombinant protein elicits broadly cross-reactive antibodies to placental Plasmodium falciparum-infected erythrocytes. Infect. Immun. 78:2248-2256.
37. Avril M, Cartwright MM, Hathaway MJ, Smith JD. 2011. Induction of strain-transcendent antibodies to placental-type isolates with VAR2CSA DBL3 or DBL5 recombinant proteins. Malar. J. 10:36. doi: 10.1186/1475-2875-10-36.
38. Magistrado PA, Minja D, Doritchamou J, Ndam NT, John D, Schmiegelow C, Massougbodji A, Dahlback M, Ditlev SB, Pinto VV, Resende M, Lusingu J, Theander TG, Salanti A, Nielsen MA. 2011. High efficacy of anti DBL4varepsilon-VAR2CSA antibodies in inhibition of CSA-binding Plasmodium falciparum-infected erythrocytes from pregnant women. Vaccine 29:437-443.
39. Bigey P, Gnidehou S, Doritchamou J, Quiviger M, Viwami F, Couturier A, Salanti A, Nielsen MA, Scherman D, Deloron P, Tuikue Ndam N. 2011. The NTS-DBL2X region of VAR2CSA induces cross-reactive antibodies that inhibit adhesion of several Plasmodium falciparum isolates to chondroitin sulfate A. J. Infect. Dis. 204:1125-1133.